The SecureCap™ Child-Resistant (CR) Closures from Comar are in response to the Consumer Product Safety Commission (CPSC) rule requiring child-resistant (CR) packaging for products containing the equivalent of 0.08 milligrams or more of imidazoline.
The SecureCap™ Child-Resistant Closures utilize Comar’s existing two-piece push-and-turn technology with CR and SF (senior friendly) effectiveness.
The technology is a natural progression for Comar and comprised of a two-component system (inner and outer) originally designed and utilized in the market for the company’s dropper assemblies. The CR dropper caps are currently standard stocked items in 20-mm, 24-mm
and 28-mm sizes.
CPSC mini protocol tests were completed with positive results in mid-May 2013 with a full protocol to follow, and commercialization expected later this year.
Sizes ranging from 13mm to 15mm for ophthalmic and 15mm to 18mm for nasal will be offered and various sample sizes are now available.
SecureCap™ Child-Resistant (CR) Closures are patent pending and will be CE marked. System components are manufactured in facilities that comply with current Good Manufacturing Practices (cGMP) and ISO 9001:13485 quality standards. Comar provides manufacturing services for pharmaceutical and Class 1 medical device molding.
